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Abstract
In vivo studies have shown that cancer-associated skeletal muscle wasting (cachexia) is mediated by two cytokines, tumor
necrosis factor-K (TNF) and interleukin-6 (IL-6). It has been unclear from these studies whether TNF exerts direct effects on
skeletal muscle and/or whether these effects are mediated via IL-6. Previous studies from our laboratory have shown that
TNF induces IL-6 mRNA expression in cultured skeletal muscle cells. To further investigate the relationship between TNF
and IL-6, the effects of TNF and IL-6 on protein and DNA dynamics in murine C2C12 skeletal myotube cultures were
determined. At 1000 U/ml, TNF induced 30% increases in protein and DNA content. The effects of TNF on protein
accumulation were inhibited by aphidicolin, an inhibitor of DNA synthesis. IL-6 mimicked the effects of TNF on C2C12
cultures, inducing a 32% increase in protein accumulation and a 71% increase in the rate of protein synthesis. IL-6 also
decreased expression of mRNA for several proteolytic system components, including ubiquitin 2.4 kb (51%) and 1.2 kb
(63%), cathepsin B (39%) and m-calpain (47%), indicating that IL-6 acts on both protein synthesis and degradation.
Incubation of murine C2C12 myotube cultures with TNF (1000 U/ml) in the presence of a polyclonal mouse anti-IL-6
antibody resulted in an abolishment of the effects of TNF on protein synthesis, but did not inhibit TNF-induced stimulation
of DNA synthesis. These findings indicate that the effects of TNF on muscle protein synthesis are mediated by IL-6, but that
TNF exerts IL-6-independent effects on proliferation of murine skeletal myoblasts. ß 2002 Elsevier Science B.V. All rights
reserved.
Keywords: Tumor necrosis factor K ; Skeletal muscle; Interleukin-6; Cytokine
1. Introduction
Cachexia (and muscle wasting) occurs in more
than two thirds of patients who die with advanced
cancer and is estimated to be responsible for the
death of 22% of cancer patients [1]. Indeed, the de-
gree of cachexia is inversely correlated with the sur-
vival time of the patient and it always implies a poor
prognosis [2^4]. At the biochemical level, various ex-
planations can be found to account for cancer-in-
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duced cachexia, but basically the presence of both
tumoral and humoral (mainly cytokines, tumor ne-
crosis factor-K (TNF) in particular) compounds is
associated with depletion of fat stores and muscular
tissues [5]. The balance between pro-in£ammatory
cytokines, their soluble receptors and the anti-in£am-
matory cytokines plays a key role in the development
of the cachectic syndrome [6].
Although there is little doubt that TNF and other
cytokines, such as interleukin-6 (IL-6) [7], are in-
volved in muscle wasting in many pathological con-
ditions in addition to cancer cachexia (see [6] for re-
view), there is still some controversy on the
mechanisms involved in the muscle wasting process.
Using incubated rat soleus and EDL muscles, Llo-
vera et al. [8] have demonstrated that the action of
the cytokine on the induction of ubiquitin-dependent
proteolysis can be direct. In addition, several lines of
research indicate that TNF has direct e¡ects in
muscle cell cultures. Miller et al. [9], using human
primary myoblasts, showed that TNF, in addition
to inhibiting the expression of K-cardiac actin (a
muscle-speci¢c gene whose expression is observed
at low levels in human myoblasts), inhibited muscle
di¡erentiation (measured taking into account skeletal
muscle actin and myosin heavy-chain mRNA con-
tent). Similarly, Szalay et al. [10], using C2 myo-
blasts, reported that TNF was able to facilitate the
proliferation and aggregation of myoblasts but
strongly inhibited the expression of myogenic tran-
scription factors (myoD and myogenin), and there-
fore there was no myo¢lament protein synthesis and
no di¡erentiation. Conversely, Ji et al. [11] showed
that TNF suppressed myoblast proliferation alone or
in combination with interleukin-1 (IL-1). In addition,
although fusion was retarded, myosin synthesis was
not a¡ected either by TNF, IL-1 or a combination of
the two cytokines. Guttridege et al. [12], using di¡er-
entiating C2C12 cells, have shown that TNF-induced
activation of NF-UB inhibited skeletal muscle di¡er-
entiation by suppressing MyoD mRNA at the post-
transcriptional level. In contrast, in di¡erentiated
myotubes, interferon-Q (IFN-Q), in addition to
TNF, was required for NF-UB-dependent downregu-
lation of MyoD and dysfunction of skeletal myo¢b-
ers. Other work also supports an involvement of NF-
UB in the action of TNF on muscle cell cultures [13].
From these observations it seems quite clear that
TNF can have di¡erent e¡ects on myoblasts versus
already di¡erentiated muscle ¢bers. Cytokines, other
than TNF, have also been proposed to have a role in
muscle di¡erentiation. Thus, human muscle satellite
cell proliferation in vitro has been suggested to be
regulated by autocrine secretion of IL-6 [14].
In a previous study we have reported that TNF
can either decrease or increase protein accumulation
in muscle cell cultures, depending on its concentra-
tion [15]. Thus, at concentrations below 1 U/ml it
clearly stimulates protein synthesis, whereas at higher
concentrations (100 U/ml) it favors myo¢brillar pro-
tein accumulation. Bearing all this in mind, the main
aim of the present investigation was to determine
how much of the TNF e¡ect on cultured muscle
¢bers was IL-6 dependent.
2. Experimental procedures
2.1. Materials
Recombinant murine TNF-K, recombinant murine
IL-6 and polyclonal anti-mouse anti-IL-6 were ob-
tained from PeproTech (London, UK). Radiochem-
icals were purchased from Amersham International
(Amersham, Bucks, UK). All other biochemicals
were reagent grade and obtained from Sigma Chem-
ical Co. (St. Louis, MO, USA) or from Roche Diag-
nostic (Barcelona, Spain).
2.2. Cell culture
C2C12 mouse skeletal muscle cells were obtained
from the American Type Culture Collection. Cells
were passaged in high-glucose Dulbecco’s modi¢ed
Eagle’s medium (DMEM) supplemented with 10%
fetal bovine serum (FBS), 100 units of penicillin/ml,
100 Wg of streptomycin/ml, 25 ng fungizone/ml, 110
Wg sodium pyruvate/ml, and 2 mM L-glutamine in a
humidi¢ed atmosphere of 5% CO2 and 95% air at
37‡C. For experimental analyses, cells were seeded
at 3.7U104 cells/cm2 in 10% FBS/DMEM until
they reached 90^100% con£uence 24 h later. At this
time, the medium was replaced by DMEM contain-
ing 10% horse serum (HS) for induction of di¡eren-
tiation. Abundant myotube formation, monitored
microscopically, occurred after 4 days in 10% HS/
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DMEM. Such fused myotubes cultures were utilized
for experimental analyses, with hour 0 considered the
time of TNF, insulin-like growth factor-I or insulin
addition to the cultures; cultures were exposed to the
di¡erent treatments for 1^72 h and all cells were
collected at the end of incubations, being in all cases
day 7 after transferring cells to 10% HS/DMEM.
Culture medium, growth factors and cytokines were
replaced daily.
2.3. Total protein content
For total protein determination, cells were plated
in 24-well plates. After various incubation periods,
monolayers were washed twice with ice-cold PBS
(200 mM NaCl, 8 mM Na2HPO4, 2.7 mM KCl,
1.47 mM KH2PO4, pH 7.4). Then, 10% trichloroace-
tic acid (TCA) was added to lyse cells and precipitate
cell proteins. After at least 1 h at 4‡C, monolayers
were rinsed once with ice-cold 10% TCA and pro-
teins were dissolved in 0.5 M NaOH containing 0.1%
Triton X-100 at 37‡C (at least 1 h) and the mono-
layers collected quantitatively. Protein content was
determined using the BCA assay (Pierce Chemical
Co.).
2.4. Rates of protein synthesis
To determine the rates of protein synthesis, myo-
tubes in six-well plates were incubated in non-radio-
active experimental medium (DMEM supplemented
with 10% HS with or without TNF) for various pe-
Fig. 1. E¡ect of di¡erent TNF concentrations on total protein and DNA content in C2C12 myotubes. Myotubes were exposed to var-
ious concentrations of TNF for 72 h. Total protein content values are expressed as mg of protein/plate, and total DNA content are
expressed as arbitrary units. The results are mean þ S.E.M. for ¢ve di¡erent experiments. Statistical signi¢cance of the results (Stu-
dent’s t-test) : *P6 0.05, **P6 0.01, ***P6 0.001.
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riods of time. The culture medium was replaced
with experimental medium containing 1 WCi of
[3H]phenylalanine/ml for the ¢nal hour of incuba-
tion. Cells were rinsed twice in ice-cold HBSS-phe-
nylalanine. Monolayers were precipitated with 1 ml
10% TCA at least 1 h at 4‡C and, after washing once
with ice-cold 10% TCA, the precipitated protein was
dissolved by incubation at least 1 h at 37‡C in 1 ml
of 0.5 M NaOH containing 0.1% Triton X-100. Ra-
dioactivity was determined using a liquid scintillation
counter and protein content was determined using
the BCA assay.
2.5. RNA isolation and Northern blot analysis
Myotubes were grown in 10-mm dishes and
treated with or without TNF for di¡erent periods.
RNA was extracted from 7-day-old myotubes using
the acid guanidinium isothiocyanate/phenol/chloro-
form method [16]. RNA samples were denatured,
subjected to electrophoresis in 1.2% agarose gels con-
taining 6.3% formaldehyde and transferred to Hy-
bond N membranes (Amersham). RNA was ¢xed
to the membranes by UV cross-linking. The RNA
in gels and on ¢lters was visualized by ethidium bro-
mide staining and photographed by UV transillumi-
nation to ensure the integrity of RNA and to con¢rm
proper transfer. RNA was transferred in 20U stan-
dard saline citrate (SSC; 0.15 M NaCl and 15 mM
sodium citrate, pH 7.0). Hybridization was done at
65‡C overnight in hybridization bu¡er (0.25 M
Na2HPO4/7% SDS/1 mM EDTA/1% BSA/10% dex-
tran sulfate), and denatured labeled probes (106^107
cpm/ml) were added. Radiolabeled probes were pre-
pared by the random primer method (Roche). The
ubiquitin probe used was a cDNA clone, provided by
Dr. M.J. Schlesinger, containing 12 pairs of the sec-
ond coding sequence plus a complete third and
fourth ubiquitin coding sequence and 120 base pairs
of the 3P-untranslated region of the chicken polyubi-
quitin gene UBI [17]. The membranes were also hy-
bridized with cDNA probes encoding rat m-calpain
(provided by John S. Elce, Department of Biochem-
istry, Queen’s University, Kingston, ON, Canada),
rat cathepsin B (provided by Dr. S.J. Chan, Baylor
College of Medicine, Division of Neuroscience,
Houston, TX, USA) and the proteasome subunit
C8 (provided by Dr. Tanaka, Institute for Enzyme
Research, University of Tokuhima, Japan). Loading
correction was carried out by performing Northern
blots with the rat 18S ribosomal subunit probe [18].
Filters were exposed to Hyper¢lm-MP (Amersham)
at 380‡C for 1^4 days and the ¢lms quanti¢ed by
scanning densitometry (Phoretix 2.51, Phoretix Inter-
national).
2.6. Statistical analysis
Statistical analysis of the data was performed by
means of Student’s t-test (two-tailed, unpaired).
Fig. 2. E¡ects of IL-6 on total protein accumulation and pro-
tein synthesis rate in C2C12 myotubes. For protein synthesis
rate estimation, myotubes were treated with IL-6 at 100 U/ml
for 48 h, and [3H]phenylalanine was added the last incubation
hour. Values (radioactivity incorporated into protein/Wg of total
protein) are expressed as a percentage of control (untreated)
cells and are mean þ S.E.M. Protein accumulation is expressed
as percentage of control (untreated) cells. Statistical signi¢cance
of the results (Student’s t-test) : *P6 0.05, ***P6 0.001.
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3. Results
At low concentration (0.001 U/ml), TNF induced
a signi¢cant decrease in protein accumulation in
C2C12 cell cultures (Fig. 1A). At higher concentra-
tions, however, TNF did not decrease protein accu-
mulation but tended to increase it. At the highest
concentration tested (1000 U/ml), TNF increased
protein accumulation approximately 30% (P6 0.01
versus untreated). At 100 U/ml TNF also increased
protein accumulation (results not shown). Protein/
DNA ratio was unchanged at all the concentrations
of TNF tested. These ¢ndings suggested that the in-
crease in protein content induced by high TNF con-
centrations was related to myoblast proliferation. To
test this possibility, TNF was administered in the
presence of aphidicolin, an inhibitor of DNA syn-
thesis. TNF was catabolic at all concentrations
tested, acting to decrease protein content more than
50% at 1000 U/ml with no decrease in DNA content.
(Fig. 1B). Consequently, the protein/DNA ratio de-
creased in a dose-dependent manner with increasing
concentrations of TNF. These observations indicate
that the increase in protein content induced by high
TNF concentrations is dependent upon myoblast
proliferation. When myoblast proliferation is inhib-
ited, TNF acts in a catabolic manner at all concen-
trations. We have previously reported that TNF in-
duces IL-6 mRNA expression in C2C12 muscle cell cultures [19]. Additionally, Cantini et al. [14] showed
that IL-6 stimulated myoblast proliferation in cul-
ture. We therefore examined the e¡ects of IL-6 on
protein accretion in C2C12 muscle cell cultures. The
addition of IL-6 (100 U/ml) to C2C12 myotubes for
48 h resulted in a 30% increase in total protein that
was correlated with an even more pronounced in-
crease (71%) in the rate of protein synthesis (Fig.
2). We also examined the e¡ect of IL-6 on expression
of proteolytic system components (Table 1 and Fig.
3). IL-6 caused 51% and 63% decreases in the 2.4 and
1.2 kb ubiquitin transcripts, respectively. IL-6 also
signi¢cantly decreased cathepsin B mRNA by 39%,
and m-calpain mRNA by 47%. Therefore, the in-
crease in protein accumulation induced by IL-6 was
likely the result of both an increased rate of protein
synthesis together and a decreased rate of protein
degradation. The e¡ects of IL-6 and TNF on protein
accumulation in C2C12 myotube cultures were sim-
ilar, both inducing an approximate 30% increase in
Fig. 3. Northern blots of the di¡erent proteolytic system com-
ponents in C2C12 myotubes. Expression of the di¡erent proteo-
lytic systems components mRNAs was detected after hybridiza-
tion with cDNA probes. Loading correction was carried out by
performing blots with the rat 18S ribosomal subunit probe (for
more details see Section 2). Autoradiographs were subjected to
scanning densitometry.
Table 1
mRNA content of di¡erent proteolytic system components in
C2C12 cells
mRNA Experimental group
Ubiquitin 2.4 kb Control 100 þ 7
IL-6 41 þ 11*
Ubiquitin 1.2 kb Control 100 þ 26
IL-6 40 þ 5*
E2 Control 100 þ 19
IL-6 62 þ 9
C8 Control 100 þ 24
IL-6 84 þ 14
Cathepsin B Control 100 þ 10
IL-6 61 þ 9*
m-Calpain Control 100 þ 6
IL-6 53 þ 2*
The results are mean values þ S.E.M. for ¢ve di¡erent experi-
ments. The values are arbitrary units. Statistical signi¢cance of
the di¡erences (Student’s t-test) : *P6 0.05.
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protein content at the highest concentrations tested.
In order to determine whether the TNF e¡ect was
mediated by IL-6, C2C12 myotubes were incubated
with 1000 U/ml TNF with and without an anti-IL-6
neutralizing antibody (Table 2). Neutralization of
IL-6 inhibited the TNF-induced increase in protein
synthesis, but had no e¡ect on TNF-induced myo-
blast proliferation. These ¢ndings indicate that the
e¡ects of TNF on muscle protein synthesis are medi-
ated by IL-6, but that TNF exerts IL-6 independent
e¡ects on proliferation of murine skeletal myoblasts.
4. Discussion
Bearing in mind that skeletal muscle constitutes
approximately 45% of body weight, and that it rep-
resents the main source of protein loss during wast-
ing diseases, studies concerning the e¡ects of TNF on
this tissue have proliferated over the last decade.
However, many of the ¢ndings are divergent and
therefore generate doubts as to whether or not this
cytokine does have a role in muscle wasting (see
[5,20] for review). One of the very ¢rst observations
concerning an action of TNF in skeletal muscle was
reported by Tracey et al. [21], when it was observed
that the cytokine could alter the membrane potential
of the muscle cell. Miller et al. [9] studied the e¡ects
of the cytokine on human muscle cell cultures and
demonstrated that TNF is capable of discriminating
between undi¡erentiated and di¡erentiated cells (i.e.,
myoblasts and myotubes). Thus, TNF added to myo-
blasts could prevent both the expression of muscle-
speci¢c genes (both skeletal and cardiac K-actin and
myosin heavy-chain) and fusion into terminally dif-
ferentiated myotubes. The authors speculate that,
since TNF has been implicated in the mammalian
response to stress and in the pathogenesis of septic
shock and cachexia, the target of TNF action on
skeletal muscle may be the satellite cell population,
which has the capacity to proliferate under condi-
tions of muscle injury. Under these conditions,
TNF may function to inhibit satellite cell di¡erentia-
tion while sparing di¡erentiated muscle cells. Simi-
larly, Szalay et al. [10], using murine C2 myoblasts,
have shown that although TNF had a positive e¡ect
on the early steps of myogenesis by enhancing pro-
liferation and aggregation of myoblast cells, strongly
inhibited the expression of those myogenic transcrip-
tion factors (myoD and myogenin), which are known
to be responsible for inducing the expression of
muscle-speci¢c genes.
The results presented here allow one to suggest
that the action of the cytokine on muscle cell cultures
is basically catabolic at any of the concentrations
tested; however, at high concentrations of the cyto-
kine, IL-6 mRNA gene expression is increased [19],
and the release of this cytokine may facilitate he
enhanced protein accumulation. Although human
muscle satellite cell proliferation in vitro seems to
be regulated by autocrine secretion of IL-6 [14], the
data obtained here do not support that IL-6 may be
involved in the proliferative e¡ects (as measured by
the incorporation of [3H]thymidine into DNA) of
high TNF concentrations. Therefore, IL-6 is only
partially involved in the observed e¡ects of TNF
on C2C12 myotubes. Two possibilities can be sug-
gested. TNF may cause proliferation and this, in
turn, generates IL-6 which causes protein accretion.
This would explain why when IL-6 is inhibited, pro-
liferation is not a¡ected. On the other hand, there
may be two TNF pathways leading to increased pro-
tein, a proliferation-dependent/IL-6 independent
pathway and a proliferation-independent/IL-6 depen-
dent pathway. Distinguishing between these two pos-
sibilities will require further work.
Table 2
E¡ects of anti-IL-6 on protein synthesis and cell proliferation rate
Additions Rate of protein synthesis
(dpm/Wg protein)
Total [3H]thymidine incorporation
(dpmU1033)
None 48.5 þ 1.98 194.5 þ 5.8
TNF (1000 U/ml) 53.3 þ 1.55*** 224.5 þ 2.2**
TNF+anti-IL-6 (100 U/ml+0.6 mg/ml) 43.5 þ 2.2222 223.4 þ 6.3**
The results are mean values þ S.E.M. for ¢ve di¡erent experiments. Statistical signi¢cance of the di¡erences (Student’s t-test) :
***P6 0.001 vs. control; 22P6 0.01 vs. TNF.
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